151 related articles for article (PubMed ID: 2929588)
1. Vasculitis in hairy cell leukemia: rapid response to interferon alpha.
Gómez-Almaguer D; Herrera-Garza JL; Garcia-Guajardo BM; Garcia-Taboada BE
Am J Hematol; 1989 Apr; 30(4):261-2. PubMed ID: 2929588
[TBL] [Abstract][Full Text] [Related]
2. Effect of alpha-interferon therapy on bone marrow fibrosis in hairy cell leukemia.
Laughlin M; Islam A; Barcos M; Meade P; Ozer H; Gavigan M; Henderson E; Han T
Blood; 1988 Sep; 72(3):936-9. PubMed ID: 3416078
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow histological modifications induced by alpha interferon in hairy cell leukemia.
Lambertenghi-Deliliers G; Benazzi E; Cortelezzi A; Polli EE
Acta Haematol; 1987; 77(4):203-7. PubMed ID: 3115030
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of bone marrow changes during the treatment of hairy cell leukemia with interferon alpha.
Flandrin G; Sigaux F; Castaigne S; Degos L
Cancer Treat Rev; 1985 Dec; 12 Suppl B():17-22. PubMed ID: 3833326
[No Abstract] [Full Text] [Related]
5. Skeletal complications in hairy cell leukemia: diagnosis and therapy.
Lembersky BC; Ratain MJ; Golomb HM
J Clin Oncol; 1988 Aug; 6(8):1280-4. PubMed ID: 3411340
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow histology in patients with hairy cell leukemia (HCL) treated by human lymphoblastoid interferon.
Coci A; Castello A; Pagnucco G; Magrini U; Merante S; Brusamolino E; Castelli G; Canevari A; Bernasconi C
Haematologica; 1987; 72(2):143-9. PubMed ID: 3114069
[No Abstract] [Full Text] [Related]
7. Alpha interferon treatment of patients with hairy-cell leukaemia.
Hagberg H; Alm G; Björkholm M; Glimelius B; Killander A; Simonsson B; Sundström C; Ahre A
Scand J Haematol; 1985 Jul; 35(1):66-70. PubMed ID: 4048862
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic effectiveness of the Russian drug reaferon in hairy cell leukemia].
Grigor'eva MA; Polianskaia AM
Gematol Transfuziol; 1990 Jun; 35(6):16-9. PubMed ID: 2203666
[TBL] [Abstract][Full Text] [Related]
9. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
Bardawil RG; Ratain MJ; Golomb HM; Bitter MA; Groves C; Vardiman JW
Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760
[TBL] [Abstract][Full Text] [Related]
10. Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.
Golomb HM; Jacobs A; Fefer A; Ozer H; Thompson J; Portlock C; Ratain M; Golde D; Vardiman J; Burke JS
J Clin Oncol; 1986 Jun; 4(6):900-5. PubMed ID: 3519880
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow infiltration in hairy cell leukemia after interferon therapy detected by magnetic resonance imaging.
Silingardi V; Davolio-Marani S; Federico M; Piccinini L; Frassoldati A; Sarti M; Burani A; Canossi G
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):209-13. PubMed ID: 2702977
[TBL] [Abstract][Full Text] [Related]
12. Acute necrotising vasculitis in hairy cell leukemia--rapid response to cladribine: case report and a brief review of the literature.
Seshadri P; Hadges S; Cropper T
Leuk Res; 2000 Sep; 24(9):791-3. PubMed ID: 10978784
[TBL] [Abstract][Full Text] [Related]
13. Alpha interferon for induction of remission in hairy-cell leukemia.
Quesada JR; Reuben J; Manning JT; Hersh EM; Gutterman JU
N Engl J Med; 1984 Jan; 310(1):15-8. PubMed ID: 6689734
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evaluation of bone marrow involvement in hairy cell leukemia during interferon therapy.
Soligo D; Lambertenghi-Deliliers G; Berti E; Polli N; Polli EE
Blut; 1987 Aug; 55(2):121-6. PubMed ID: 3300818
[TBL] [Abstract][Full Text] [Related]
15. Reversal of infection with Mycobacterium avium intracellulare by treatment with alpha-interferon in a patient with hairy cell leukemia.
Maziarz RT; Tepler I; Antin JH; Keroack MA; Churchill WH; Holmes W; Rappeport J
Ann Intern Med; 1988 Aug; 109(4):292-4. PubMed ID: 3395039
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow changes in patients with hairy cell leukemia treated by recombinant alpha 2-interferon.
Naeim F; Jacobs AD
Hum Pathol; 1985 Dec; 16(12):1200-5. PubMed ID: 4065882
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging of bone marrow in hairy cell leukemia: correlation with clinical response to alpha-interferon.
Thompson JA; Shields AF; Porter BA; Olson DO; Rubin E; Kidd P; Fefer A
Leukemia; 1987 Apr; 1(4):315-6. PubMed ID: 3669752
[TBL] [Abstract][Full Text] [Related]
18. Tumorous manifestation of hairy cell leukemia after long-term treatment with interferon alpha.
Huhn D; Oertel J; Serke S; Kaiser D; Schmitt-Gräff A; Stein H
Ann Hematol; 1995 Feb; 70(2):103-5. PubMed ID: 7880923
[TBL] [Abstract][Full Text] [Related]
19. Toxicity and bone marrow response of patients with hairy cell leukemia treated with biosynthetic (recombinant) alpha-2-interferon.
Jacobs AD; Naiem F; Champlin RE; Golde DW
Blut; 1985 Jan; 50(1):33-4. PubMed ID: 3967099
[No Abstract] [Full Text] [Related]
20. Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha 2 interferon for hairy cell leukemia.
Bardawil RG; Groves C; Ratain MJ; Golomb HM; Vardiman JW
Am J Clin Pathol; 1986 Feb; 85(2):194-201. PubMed ID: 3946302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
